Vaishali Pharma Ltd
VAISHALIVaishali Pharma Ltd
VAISHALI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 211.33 | 5.38 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.23 | 6.64 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Mankind Pharma Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 69.89 | 64.90 | 69.42 | 77.07 | 62.26 | 55.58 | 77.61 | 71.89 | 88.31 | 101.66 | ||||||||||
Raw Materials | 62.07 | 53.94 | 60.61 | 67.78 | 50.99 | 45.86 | 63.54 | 57.10 | 71.75 | 98.23 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 1.56 | 1.59 | 2.04 | 2.13 | 1.27 | 1.19 | 1.36 | 1.30 | 1.40 | |||||||||||
| Selling & Administrative Expenses | 0.00 | 2.38 | 2.97 | 2.15 | 2.62 | 1.94 | 4.06 | 4.28 | 3.44 | |||||||||||
| Operating & Other expenses | 2.53 | 2.59 | -0.65 | 0.96 | 4.31 | 2.13 | -0.03 | -2.39 | 8.03 | |||||||||||
EBITDA | 3.73 | 4.40 | 4.45 | 4.05 | 3.07 | 4.46 | 8.68 | 11.60 | 3.69 | 3.43 | ||||||||||
| Depreciation/Amortization | 0.37 | 0.28 | 0.25 | 0.27 | 0.44 | 0.43 | 0.46 | 0.50 | 0.51 | 0.50 | ||||||||||
| PBIT | 3.36 | 4.12 | 4.20 | 3.78 | 2.63 | 4.03 | 8.22 | 11.10 | 3.18 | 2.93 | ||||||||||
| Interest & Other Items | 3.37 | 3.10 | 2.85 | 2.66 | 2.56 | 2.63 | 2.49 | 2.26 | 2.27 | 1.59 | ||||||||||
| PBT | -0.01 | 1.02 | 1.35 | 1.12 | 0.07 | 1.40 | 5.73 | 8.84 | 0.91 | 1.34 | ||||||||||
| Taxes & Other Items | 0.03 | 0.33 | 0.55 | 0.42 | 0.05 | 0.36 | 1.70 | 2.24 | 0.21 | 0.25 | ||||||||||
| Net Income | -0.04 | 0.69 | 0.80 | 0.70 | 0.02 | 1.04 | 4.03 | 6.60 | 0.70 | 1.09 | ||||||||||
| EPS | -0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.10 | 0.38 | 0.63 | 0.07 | 0.10 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Investor Presentation
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vaishali Pharma Ltd | 329.08 | 5.38 | — |
| Sun Pharmaceutical Industries Ltd | 45.62 | 6.51 | 0.74% |
| Mankind Pharma Ltd | 62.83 | 12.55 | — |
| Cipla Ltd | 28.94 | 4.45 | 0.88% |
Price Comparison
Compare VAISHALI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 4.97%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
May 2024
Jun 2024
Jul 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
VAISHALI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Vaishali Pharma rose 15.88% to Rs 1.97 crore in the quarter ended September 2024 as against Rs 1.70 crore during the previous quarter ended September 2023. Sales rose 65.39% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 12.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.7912.57 65 OPM %11.6421.08 - PBDT2.752.48 11 PBT2.632.36 11 NP1.971.70 16 Powered by Capital Market - Live
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October 2024.Powered by Capital Market - Live
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 August 2024.Powered by Capital Market - Live
Vaishali Pharma announced that the 17th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net profit of Vaishali Pharma rose 6.92% to Rs 1.70 crore in the quarter ended June 2024 as against Rs 1.59 crore during the previous quarter ended June 2023. Sales rose 34.72% to Rs 18.08 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.0813.42 35 OPM %13.0017.21 - PBDT2.392.24 7 PBT2.272.12 7 NP1.701.59 7 Powered by Capital Market - Live
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Stocks that will see action on March 2, 2023
Vaishali Pharma bags orders worth Rs 600 crore for purchase of antibiotic products
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2.76%, vs industry avg of 9.04%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.04% to 0.02%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 0%, vs industry avg of 15.28%